Drug delivery devices enable pharmaceutical manufacturers to differentiate their new drugs from already existing products, thereby providing ways for extending patent protection, as well as discover novel treatments. Parenteral drug administration is among the most common route of drug delivery and the major advantage associated with it is high bioavailability of the active pharmaceutical ingredient. Currently, parenteral drug delivery devices constitute the major share of the global drug delivery devices market.
Factors such as increasing usherance of novel biological products and biosimilar are leading to the development of advanced parenteral drug delivery devices for effective delivery of these products. In the drug market, polymer-encapsulated medicines, hormones and central nervous system agents are gaining importance that further requires parenteral drug delivery. Also, wide availability of pen injectors, IV catheters, vial bag infusion systems and retractable pre-fillable syringes will lead to increased market share of these parenteral drug delivery devices as they provide advantages of infection prevention.
The increasing prevalence of chronic disorders such as diabetes, cardiovascular diseases and cancer, growing demand for self-administration and home healthcare devices; the rising incidence of chronic diseases such as cardiovascular diseases, diabetes, and cancer; the growing focus on pediatric and geriatric patients; and the increasing demand for minimally invasive surgeries are other factors contributing to growth in the drug delivery market. In addition, pharmaceutical companies are increasingly adopting drug delivery technologies to differentiate their products in the highly competitive environment.
The global advanced parenteral drug delivery devices market is segmented by applications, products, and geography. On the basis of products, the global advanced parenteral drug delivery devices market is classified into IV catheters, pre-fillable syringes, hypodermic syringes, injector cartridges, and other parenteral delivery devices. In addition, on the basis of applications, the global advanced parenteral drug delivery devices market is bifurcated as central nervous system agents, hormones & related agents, respiratory agents, gastrointestinal agents, anti-infective agents, cardiovascular agents, genito-urinary agents, and nutritional agents.
The global advanced parenteral drug delivery devices market is segmented by region into Asia-Pacific (APAC), Europe, North America, Latin America, and Middle East and Africa. Factors such as increasing usherance of novel biological products and biosimilar are leading to the development of advanced parenteral drug delivery devices for effective delivery of these products. Also, wide availability of pen injectors, IV catheters, vial bag infusion systems and retractable pre-fillable syringes will lead to the increased market share of these parenteral drug delivery devices as they provide advantages of infection prevention.
North America is analyzed to possess the largest market share in terms of revenue owing to the rising patient awareness levels and increasing acceptance and adoption of high-tech healthcare systems. On the other hand, the European market trails the North American market in terms of revenue, owing to increasing acceptance and adoption of high-tech healthcare systems. The global advanced parenteral drug delivery devices market in Asia-Pacific is analyzed to be the most lucrative market owing to the increasing penetration of advanced healthcare technology and products, and rapidly improving healthcare infrastructure in emerging economies of India and China. Thus, the Asia-Pacific region serves as a great untapped opportunity for key market players in this industry.
The global advanced parenteral drug delivery devices market is highly competitive with respect to pricing and technological advancements. A few of the key players dominating the global advanced parenteral drug delivery devices market include Abbott Laboratories, AptarGroup Incorporated, Amgen Incorporated, AstraZeneca plc, Becton, Dickinson and Company, Baxter International Incorporated, Boston Scientific Corporation, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Novartis AG, Roche Holding Limited, and Pfizer Incorporated, among others.
The global long term care market size is expected to reach around 1,621 Mn by 2026 and growing at a CAGR of around 7% over the forecast period 2019 to 2026. Long term care is a term used for a variety of services, which are specially designed to meet a person's short term and long term requirement for health and personal care. This is also termed as Activities of Daily Living or ADLs, when it is served for personal care, such as dressing,
The global precision medicine market size is expected to reach around US$ 84 Bn by 2026 and is anticipated to grow at a CAGR of around 10% in terms of revenue during the forecast period 2019 to 2026. Precision medicine is an approach to patient care that enables physicians to choose medicines that assist patients to understand their disease genetically. This can also be called custom medicine. The report provides analysis of global precis
The Global Comprehensive Metabolic Panel (CMP) Testing Market size is expected to reach over US$ 18,380 Mn by 2026 and growing at a CAGR of around 7.0% from 2019 to 2026. The Comprehensive Metabolic Panel (CMP) is a commonly ordered set of 14 tests that give doctor a significant data about the present status of kidneys, electrolyte, liver and acid / base balance as well as blood sugar and blood proteins. Abnormal findings, and in particular abnormal resul
The global recreational oxygen equipment market is expected to grow at a CAGR of around 16.3% from 2019 to 2026 and reach the market value of around 307 Mn by 2026. Recreational Oxygen is also termed as consumer oxygen, which is used to enhance brain functioning and also to improve athletic endurance. Recreational oxygen can’t be replaced with the medical oxygen as medical oxygen is used for treatment purposes and is controlled by the FDA as a thera
The global plasmid DNA manufacturing market size is expected to reach over US$ 300 million by 2026 and growing at a CAGR of 20% from forecast period 2019 to 2026. There are continuous development activities carried by major players in order to test plasmid DNA applicability. Usually plasmid DNA is prepared by cesium chloride density ultracentrifugation process and it has wide applications such as c
The global powered surgical instrument market is expected to grow at a CAGR of around 4.0% from 2019 to 2026 and reach the market value of over US$2,900 Mn by 2026. Powered surgical instrument is a market of technological instruments used to assist at the time of performing neurological and orthopedic surgery. This surgical powered instrument is categorized by product which includes high speed equipment, large bone battery/electric equipm